Market Currents
Galena Biopharma (GALE) forms a partnership with Germany's Leica Biosystems to use the latter's...
-
Thursday, December 6, 2012, 8:48 AM ETGalena Biopharma (GALE) forms a partnership with Germany's Leica Biosystems to use the latter's Bond Oracle HER2 IHC System to help select patients for the Phase III trials of Galena's NeuVax breast cancer treatment. On Tuesday, Galena signed a deal with Teva for the commercialization of NeuVax in Israel. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
